Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Chiang Syin
Chiang Syin
Positions:

Chief Quality Officer

Company:

WuXi Biologics

Dr. Chiang Syin is currently the Chief Quality Officer and Senior Vice President at WuXi Biologics, mainly responsible for QA, QC and RA. Prior to joining WuXi Biologics, he served as a Gates Project International Expert for CFDI of CFDA (now renamed NMPA). During the nearly 30-year career at the U.S. FDA, Dr. Syin has accumulated abundant experience in regulatory review and GMP compliance of biological and biotech products. He has been actively involved in FDA drug/biologics regulatory policy and guidance development including Vaccines CMC and Phase I GMP guidance documents as well as the 2011 Process Validation guidance revision. Dr. Syin received the bachelor degree in biology at Tunghai University in Taiwan, China and obtained a Ph.D. in Chemistry at Catholic University of America after which he undertook the post-doctorate study at the U.S. National Institutes of Health.